Differential kinetics of plasma CD105 and transforming growth factor β expression early in human acute pancreatitis

Pancreas

Volumn 32, Issue 2, 2006, Pages 152-158

  Jamdar, Saurabh ^a   Al Mowallad, Abdul Fattah ^b   Kumar, Shant ^b   Siriwardena, Ajith K ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CD105; Human acute pancreatitis; TGF

Indexed keywords

ENDOGLIN; IMMUNOSUPPRESSIVE AGENT; LIGAND; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ACUTE PANCREATITIS; ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KINETICS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VENOUS BLOOD;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APACHE; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; PANCREATITIS; RECEPTORS, CELL SURFACE; REFERENCE VALUES; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646068065     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000203962.16630.f4     Document Type: Article

References (27)

1. Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5:132-144.
2. Inoue K, Hirota M, Kimura Y, et al. Further evidence for endothelin as an important mediator of pancreatic and intestinal ischemia in severe acute pancreatitis. Pancreas. 2003;26:218-223.
3. Eibl G, Buhr HJ, Foitzik T. Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block? Intensive Care Med. 2002;28:139-146.
4. Chen HM, Sunamura M, Shibuya K, et al. Early microcirculatory derangement in mild and severe pancreatitis models in mice. Surg Today. 2001;31:634-642.
5. Gloor B, Muller CA, Worni M, et al. Late mortality in patients with severe acute pancreatitis. Br J Surg. 2001;88:975-979.
6. Friess H, Lu Z, Riesle E, et al. Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. Ann Surg. 1998;227:95-104.
7. Riesle E, Friess H, Zhao L, et al. Increased expression of transforming growth factor betas after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut. 1997;40:73-79.
8. Kihara Y, Tashiro M, Nakamura H, et al. Role of TGF-beta1, extracellular matrix and matrix metalloproteinase in the healing process of the pancreas after induction of acute necrotizing pancreatitis using arginine in rats. Pancreas. 2001;23:288-295.
9. Krupinski J, Kumar P, Kumar S, et al. Increased expression of TGF-beta1 in brain tissue after ischemic stroke in humans. Stroke. 1996;27:852-857.
10. Duff SE, Li CE, Garland JM, et al. CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 2003;17:984-992.
11. Li CG, Bethel H, Wilson PB, et al. The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease. Atherosclerosis. 2000;152:249-256.
12. Matsuno H, Yudoh K, Uzuki M, et al. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis. J Rheumatol. 2002;29:890-895.
13. Ribatti D, Cantatore FP, Vacca A, et al. Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane. Clin Rheumatol. 1998;17:115-120.
14. Freemont AJ, Jeziorska M, Hoyland JA, et al. Mast cells in the pathogenesis of chronic back pain: a hypothesis. J Pathol. 2002;197:281-285.
15. Cheifetz S, Bellon T, Cales C, et al. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem. 1992;267:19027-19030.
16. Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res. 2004;53:585-595.
17. Imai K, Hiramatsu A, Fukushima D, et al. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J. 1997;322:809-814.
18. Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, et al. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem. 2002;277:29197-29209.
19. Hardman J, Shields C, Schofield D, et al. Intravenous anti-oxidant modulation of end-organ damage in L-arginine-induced experimental acute pancreatitis. Pancreatology. 2005;5:380-386. [e-pub ahead of print].
20. Dugernier T, Laterre PF, Reynaert M, et al. Compartmentalization of the protease-antiprotease balance in early severe acute pancreatitis. Pancreas. 2005;31:168-173.
21. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis; September 11-13, 1992; Atlanta, GA. Arch Surg. 1993;128:586-590.
22. Nakae H, Endo S, Inoue Y, et al. Matrix metalloproteinase-1 and cytokines in patients with acute pancreatitis. Pancreas. 2003;26:134-138.
23. Li C, Wang J, Wilson PB, et al. Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer. Int J Cancer. 1998;79:455-459.
24. Ghellal A, Li C, Hayes M, et al. Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma. Anticancer Res. 2000;20:4413-4418.
25. Potten CS, Booth H, Haley JD. Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer. 1997;75:1454-1459.
26. Li C, Issa R, Kumar P, et al. CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci. 2003;116:2677-2685.
27. Lastres P, Letamendia A, Zhang H, et al. Endoglin modulates cellular responses to TGF-β1. J Cell Biol. 1996;133:1109-1121.